Announcing a new publication for Acta Materia Medica journal. Bioresponsive materials have gained prominence as innovative ...

VYNE Therapeutics Inc. (NASDAQ:VYNE) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright ...

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

FDA designates FF-10832 as an orphan drug for biliary tract cancer, promising enhanced treatment options for this aggressive ...

Curapod, a non-invasive light therapy device by Hyderabad-based startup Litemed, offers 50-60% pain relief in a 30-minute ...

HBO is a network built on quality content. The following series are no exception to that rule, but each deserves a larger audience.

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

In parallel, e-therapeutics has successfully completed GMP manufacturing of the clinical batch of ETX-312, supporting the Company’s operational readiness to progress to first-in-human dosing.

Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular ...

Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...

Using newly developed mouse models and a microglia replacement strategy, researchers show that bone marrow transplantation could be used as an ...

MannKind Corporation (NASDAQ:MNKD) is one of the 13 Best Healthcare Stocks to Buy Under $10. On May 8, Wells Fargo analyst ...